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We studied sleep patterns for three nights in 10 subjects with moderate to severe progressive supranuclear palsy and 
correlated the findings with disease severity using quantitative measures of motor, cognitive, abd eye movement 
impairment. All subjects had severe insomnia, spending 2 to 6 hours awake per night; the mean time awake per night 
for the group was more than 4 hours. Sleep latency became shorter and the number of awakenings increased with 
greater motor impairment, and total sleep time declined as dementia worsened. These findings indicate that in 
progressive supranuclear palsy insomnia is related to disease severity. Insomnia associated with progressive supranu- 
clear palsy appears to be worse than the insomnia of Parkinson's disease or Alzheimer's disease and may be due to 
degenerative changes in brain structures responsible for sleep maintenance. 
Aldrich MS, Foster NL, White RF, Bluemlein L, Prokopowict G. Sleep abnormalities in progressive 
supranuclear palsy. Ann Neurol 1989;25:577-581 
Progressive supranuclear palsy (PSP) is a degenerative 
neurological disorder characterized by impaired vol- 
untary gaze, axial rigidity, and dementia. Sleep com- 
plaints are common, and sleep studies have shown 
prolonged sleep latency, impaired sleep continuity, 
decreased or absent sleep spindles El, 21, and reduced 
amounts of rapid eye movement ( E M )  sleep f31. 
Sleep disturbance in PSP could be due to degenera- 
tive neurochemical or neuropathological changes af- 
fecting areas of the brain involved with sleep regula- 
tion. If so, sleep disturbances should increase as the 
disease worsens. In support of this hypothesis, Perret 
and Jouvet 131 found that 2 patients with severe clini- 
cal impairment had greater sleep disturbance than did 
7 patients with milder disease. In this study we sought 
to test this hypothesis further and, if we found confir- 
matory evidence that sleep disturbance correlated with 
clinical disease severity, to determine which specific 
aspects of clinical impairment correlated with sleep ab- 
normalities. 
Methods 
Ten patients (6 women and 4 men whose mean age was 67 
years; range 60-74) with clinically diagnosed PSP were in- 
cluded in the study. The patients, who were studied during 
the placebo phase of a drug trial for treatment of PSP 141, 
were rigorously evaluated to exclude other possible causes of 
dementia and rigidity. Their motor impairment ranged from 
mild (some difficulty with ambulation) to profound (bedrid- 
den and immobile). All subjects had dementia by criteria 
outlined in the Diagnostic and Statistical Manual of Mental 
Disorders [5},  with mild to moderate cognitive impairment 
(mean full-scale intelligence quotient 86 [range 75-101) by 
the Wechsler Adult Intelligence Scale-Revised). None were 
clinically depressed. 
Other than having PSP, the subjects were generally 
healthy at the time of the study. With the exception of gly- 
copyrrolate (an anticholinergic agent that does not penetrate 
to the central nervous system), all medications, including 
sedatives and dopaminergic medications, had been discon- 
tinued 3 weeks prior to the study. 
Subjects were admitted to the University of Michigan 
Clinical Research Center and underwent three sleep record- 
ings. The recordings were scheduled from 10: 30 PM to 6: 30 
AM on consecutive nights, but they were started up to 1 hour 
earlier or later, depending on the sleep habits of the subjects. 
For each sleep study, surface electrodes were applied to re- 
cord the electroencephalogram, electrooculogram, submen- 
tal electromyogram, and electrocardiogram. During the first 
night, 8 of the 10 subjects were also monitored for nasal-oral 
airflow, respiratory effort, blood oxygen saturation, and leg 
movements. 
The first night was viewed as an adaptation night, and the 
presence of periodic leg movements and sleep apnea were 
assessed. Sleep studies from the second and third nights were 
scored for sleep stages using conventional scoring criteria 
applied to each 30-second epoch of recording 161. All scor- 
ing was done by registered polysomnographic technologists 
and reviewed by an accredited clinical polysomnographer 
(M.S.A.). 
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We defined sleep latency as the time from lights out to the 
first epoch of any stage of sleep. Persistent sleep was defined 
as 5 minutes or more of continuous sleep. REM sleep latency 
was defined as the length of time from sleep onset to the first 
epoch of REM sleep. Sleep efficiency was defined as the 
proportion of time spent asleep from sleep onset to the final 
awakening. 
Motor function and voluntary eye movements were as- 
sessed independently by two observers (M.S.A., L.B.). A 
Motor Rating Scale was used to assess facial expression, 
speech, handwriting, postural stability, gait, balance, fine 
movements of the hands, and axial and limb rigidity 14). Each 
feature was rated from 0 (no abnormality) to 4 (severe im- 
pairment). Voluntary eye movements were assessed by visual 
estimation of the degrees of ocular rotation in each of four 
directions (up, down, left, right). To control for day-to-day 
variability, the Motor Rating Scale and eye movement scores 
were determined serially for each subject three times during 
the week of the sleep studies and once weekly for the next 4 
weeks. 
Neuropsychological function was assessed using the fol- 
lowing tests: Wechsler Adult Intelligence Scale-Revised, 
Mini-Mental State {7 ) ,  Buschke Selective Reminding Task 
{8), Boston Diagnostic Aphasia Examination 191, Profile of 
Moods States { lo), and Verbal Fluency examination [ 11) .  
Since some subjects were unable to complete all parts of the 
Mini-Mental State examination because of motor or speech 
impairment, the Mini-Mental State score was expressed as a 
fraction of the best possible score. 
The results of polysomnographic analysis were compared 
to published values for normal men aged 60 to 69 El21 using 
Student's t test. We correlated polysomnographic results 
with clinical variables and performed regression analysis on 
significant correlations (Statgraphics Statistical Graphics Sys- 
tem, Statistical Graphics Corporation, 1985). 
Results 
The results of the sleep studies are summarized in 
Table 1, and clinical and neuropsychometric assess- 
ments are shown in Table 2. Two representative sleep 
studies are illustrated in Figure 1. No subject spent 
less than 2 hours awake per night. Latencies to sleep 
and to REM sleep were highly variable; 4 of the sub- 
jects had REM latencies of less than 10 minutes on  one 
or both of the recording nights. 
Two subjects had sleep apnea and periodic leg 
movements. In 1 apnea was mainly central, and in the 
other it was predominantly obstructive (apneas plus 
hypopneas per hour of sleep were 34 and 60, respec- 
tively, for the 2 subjects). Periodic leg movements per 
hour of sleep were 21 and 28, respectively. We cal- 
culated mean values for polysomnographic variables in 
Table 1. Polysomnographic Results 
Published 
PSP Subjects Norms [ 12) 
Characteristic Mean SD Range Mean SD Pa 
Time awake (rnin) 245.0 60.9 127-352 44.3 43.2 <0.02 
Percent wakefulness 50.8 11.6 27-68 9.8 6.0 <0.01 
Time asleep (min) 233.8 52.2 163-348 407.3 44.6 c0.05 
Sleep efficiency (%) 58.1 10.9 44-80 90.0 7.0 <0.05 
Percent stage 1 sleep 15.9 5.9 9-27 9.5 4.0 
Percent stage 2 sleep 22.1 8.3 8-35 55.5 8.8 <0.05 
Percent stage 3-4 sleep 4.1 2.8 0-10 2.6 5.0 
Percent REM sleep 6.8 2.8 2-13 22.6 3.6 co.01 
Latency to sleep (min) 28.1 15.6 8-58 8.3 10.5 
Latency to stage 2 sleep (min) 49.4 25.9 7-100 16.7 12.4 
REM latency (min) 80.3 57.7 9-188 83.9 38.1 
No. of REM periods 3.5 1.2 1-6 4.5 0.7 
Average REM period duration (min) 9.5 3.1 6-15 23.2 5.0 c0.05 
Latency to persistent sleep (min) 66.4 61.8 19-239 
Wake after sleep (min) 9.6 12.1 0-38 
Wake during sleep (min) 172.7 49.0 88-247 34.0 <0.02 
No. of awakenings 33.3 16.7 10-69 7.5 3.7 
NO. of awakenings > 2 min 13.8 5.4 4-23 
"Significant differences from published norms all remained statistically significant when the 2 patients with sleep apnea and periodic leg 
movements were excluded. 
SD = standard deviation; REM = rapid eye movement; PSP = progressive supranudear palsy 
578 Annals of Neurology Vol 25 No 6 June 1989 






Studies No. Mean SD Range 
Motor Rating Scale score 10 37.4 11.1 25-56 
,I I1  - I I -1 I I  I , I  
RI I 
Voluntary eye movements 
Vertical degrees: up + down 




Profile of Moods States 
Verbal Fluency 
Boston Diagnostic Aphasia Examination Subtest: 
Buschke Selective Reminding Task 
Neuropsychometric studies 
Complex Ideational Material 
Subtest: Intrusions 
Subtest: Hits 
Subtest: False Alarms 
s 2  
T 
A 3  
G 
E 4  
10 15.5 7.5 0-31 
10 85.3 33.3 1-117 










A 3  
G 





I .I 1 1 1 1 l l N l l l  I I II 1 1 1 1  I I  1 1 1  1 1 1 1 1 1 1 1  111 I I I I  1 1 1 1 1  I -  I I  I I I  I 1  . I  
I 1 1  rn 1 1 1 1 l l I I  I 1  1 1 1 -  I .,.,I= I . , l I I  ..,I I I t  I I I  I. , 































~~~ ~~ ~~ ~~ ~ 
"Some subjects were unable to complete all of the tests because of motor or speech disturbance. 
IQ = intelligence quotient; SD = standard deviation 
I ,I I I I I, I I I  I.. I I I I II .I-.= I 1  I, 1 1 1 1  I 
I 
0 1 2 3 4 5 6 7 8 
HOURS OF RECORDING 
A 
L 
E REMI I 
E 
I la 
Aldrich et al: PSP and Sleep 579 
Table 3. Cowehtion of Sleep Variables with Selected Clinical Scales" 
~ 
Neuropsy chometrics 
Total Motor Subscales 
Motor Complex Full- Mini- 
Rating Facial Finger Ideational Profile Scale Memory Mental 
Characteristic Scale Movement Posture Gait Dexterity Rgidity Material of Moods IQ Quotient Status 
Total time awake .57 -.77* 
Minutes of stage .a5** .77** .88*** .95""" .87*** .79"* 
Total time asleep - .63 32' 
3-4 sleep 
Latency to sleep -.78" -.67" -.58 -.66" -.82'* -.90*'* .59 
Latency to REM sleep -.59 
Number of awakenings .82"* .73' .62 .77** .87"* .85*" -.73" .50 - S O  
Number of REM periods .80* - . 5 1  -.66 -.67 
> 2 min 
'Correlations less than .50 are not shown. 
"p < 0.05. 
**p < 0.01. 
**q < 0.001. 
IQ = intelligence quotient; REM = rapid eye movement. 
the 8 subjects without sleep apnea or periodic leg 
movements and found that only number of awakenings 
and REM latency were more than 6% different from 
the group as a whole. The 2 apneic subjects had a 
mean REM latency of 33 minutes compared with a 
mean of 92 minutes in the other 8 subjects, and they 
had 62 awakenings per night compared with 26 for the 
other 8. 
Sleep spindles were poorly formed or absent in 5 
subjects. Rapid eye movements during REM sleep 
were also reduced in 5 and appeared to be of low 
amplitude by subjective assessment. In the most im- 
paired patients, scoring of sleep stages was difficult 
because of one or more of the following factors: re- 
duced or absent eye movements during sleep that 
showed all other characteristics of REM sleep, poorly 
formed or absent sleep spindles and K-complexes, per- 
sistent electroencephalographic alpha activity during 
stage 1-2 sleep, and increased slow activity in the wak- 
ing electroencephalogram. 
Significant correlations of sleep variables with clini- 
cal scales are shown in Table 3. We performed the 
same correlational analysis excluding the 2 patients 
with sleep apnea and found that all correlations were 
similar and remained significant. Although sleep la- 
tency was longer than published norms for this age 
group, latency to sleep was inversely correlated with 
motor impairment. Overall motor impairment corre- 
lated with sleep fragmentation as measured by the 
number of awakenings (Fig 2), but it did not correlate 
with amount of time spent awake. Cognitive and eye 
movement abnormalities correlated positively with 
sleep disturbance, but the correlations were weaker 
than those between motor impairment and sleep dis- 
turbance. 
While the mean amount of stage 3-4 sleep was re- 
duced in the PSP subjects as compared with published 
norms, the amount of stage 3-4 sleep increased with 
25 r 
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Fig 2. Number of awakenings of duration of2 minutes or longer 
per night plotted against Motor Rating Scale (r = .82; p = 
0.004). 
increasing motor abnormalities. This increase was most 
likely due to increased amounts of slow electroenceph- 
alographic activity in severely affected patients. Al- 
though none of the patients were clinically depressed, 
Profile of Moods score correlated positively with the 
number of REM periods. 
Discussion 
Our findings sugest that insomnia in PSP is of moder- 
ate severity early in the disease course and is often 
associated with delayed sleep onset. As the disease 
progresses, sleep latency shortens, while insomnia be- 
comes more severe and is associated more with sleep 
fragmentation than with delayed sleep onset or with 
early morning awakening. The insomnia associated 
with PSP therefore differs from psychophysiological 
insomnia, in which difficulty falling asleep is a promi- 
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nent complaint, and from depressive insomnia, which 
is characterized by early morning awakening. The 
findings of reduced amounts of REM sleep and de- 
creased numbers of spindles were similar to those in 
previous reports 11-33. 
Our data are consistent with the hypothesis that PSP 
insomnia is due to altered brain function from neu- 
ronal loss in brain regions involved in sleep regulation. 
Pathological examinations of patients with PSP have 
shown degenerative changes in several brainstem 
structures presumed to be involved in sleep regulation, 
including the locus cedeus ,  periaqueductal gray mar- 
ter, and pontine tegmentum 1131. Although the spe- 
cific mechanisms that are responsible for sleep mainte- 
nance are not understood, the pons, midbrain, and 
basal forebrain are probably involved, and degen- 
erative changes in these brain regions could cause 
sleep fragmentation. Pons and midbrain atrophy on 
computed tomography has been found to correlate 
with clinical impairment [14]. Furthermore, dopami- 
nergic and cholinergic systems, both of which play a 
role in the regulation of sleep and REM sleep, are 
impaired in this disease 115, 161. Cholinergic neurons 
of the pedunculopontine nucleus, which may be in- 
volved in the activation of REM sleep El 71, are mark- 
edly reduced in number in PSP 1181. 
It is possible that insomnia in our subjects was due 
to factors associated with disease severity such as dis- 
comfort, impaired mobility, or nocturnal disorienta- 
tion, rather than to neuropathological changes. We did 
not monitor naps in the subjects, and it is possible that 
frequent or prolonged daytime naps contributed to 
nocturnal sleep disturbance. Although these factors 
may have contributed to insomnia and sleep disrup- 
tion, the severity of sleep disturbance we observed was 
greater than that observed in other neurological dis- 
eases associated with dementia and impaired mobility. 
Increased nocturnal wakefulness and frequent awaken- 
ings occur in Parkinson’s disease 119, 201, Alzheimer’s 
disease 121, 22}, and ischemic stroke 1231. However, 
in these conditions, nocturnal Wakefulness typically 
constitutes 20 to 40% of time in bed, rather than the 
50% we observed with PSP. We did not find evidence 
that sleep apnea, periodic leg movements, or depres- 
sion-three common causes of sleep fragmentation- 
were major contributors to the sleep disturbance in 
most of our subjects. 
If PSP insomnia is caused by degenerative neuro- 
pathological changes, additional studies that correlate 
sleep distwbance with specific areas of brain dysfunc- 
tion, as defined by imaging or neuropathological stud- 
ies, may help to determine the areas of the brain that 
are involved in sleep maintenance. 
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